A Pharmaceuticals and Healthcare ( Bulk Drug manufacturing ) entity from India is looking to raise strategic funding.

BUSINESS BRIEF

Pharma company in the field of manufacturing APIs for Therapeutic drugs and Intermediates, R&D, Custom Synthesis is looking to raise funds to restart its operations. The firm has always focused on complicated chemistries and specialty products and manufactures various Therapeutic drugs including Anti-Parkinson, Anti-Ulcerative, Anti-Asthmatic, Anti Bacterial, etc. The firm has 2 units and to set up a second plant for which they took a loan from Bank but did not get the clearance due to the vested interest of the local government. It took 26 months to get clearance from the Local government. At the same time, an untimely separate state agitation happened and non-co-operation from banks led to the company becoming NPA. That's why sales are 0.

Proposal

Capital Requirement INR 350 to 400 Mn
Justification: The firm has large domestic and international clients including Pfizer, Ranbaxy, Dr. Reddy, etc.
Funding Route

Private Equity, Strategic Investor

Extent Of Dilution

Upto 49 %

Share Holding Pattern

Promoter Group 100%

Non-Promoter Share Holder 0%

Reason For Raising Capital

Reduce Leverage,

Entity is open for Investor keen on special situation/distress assets funding.

Business Operating Information

Industry

Pharmaceuticals and Healthcare

Sub-Industry

Bulk Drug manufacturing

Division

Division`s Market Share

Not Disclosed

Division`s Growth rate in 3 years

Not Disclosed

Division`s Key Partnership`s

Not Disclosed

Division`s Buyers/Customers

Division`s Plant Location

Division`s Products/Services

Market Share %

Not Disclosed

Growth rate in 3 years

Not Disclosed

Key Partnerships

Not Disclosed

Division`s Products/Services

Market Share %

Not Disclosed

Growth rate in 3 years

Not Disclosed

Key Partnerships

Not Disclosed

Division`s Products/Services

Market Share %

Not Disclosed

Growth rate in 3 years

Not Disclosed

Key Partnerships

Not Disclosed

Business Strength

Rd strength

Justification n/a

Manufacturing strength

Justification n/a

Financial Information

2017 (in INR) 2018 (in INR) 2019 (in INR) 2020 (in INR)
Sales N.D N.D N.D N.D
EBDITA N.D N.D N.D N.D
PAT N.D N.D N.D N.D
TANGIBLE NET WORTH N.D N.D N.D N.D
LONG TERM DEBT N.D N.D N.D N.D
TOTAL DEBT N.D N.D N.D N.D
CONTACT BUSINESS

If you are interested in connecting with business please send an Expression of Interest.

SHARE VIA
CONTACT DETAILS